Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer
In recent years, numerous molecular-targeted drugs have become available for the perioperative therapy of breast cancer, bringing about a revolution in breast cancer treatment. Based on comprehensive gene expression analysis, breast cancer is classified into four subtypes, and there are limitations...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Tokyo Women's Medical University
2024-06-01
|
| Series: | Tokyo Women's Medical University Journal |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/twmuj/8/0/8_2024003/_pdf/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846109772907020288 |
|---|---|
| author | Eiichiro Noguchi Sadako Akashi-Tanaka |
| author_facet | Eiichiro Noguchi Sadako Akashi-Tanaka |
| author_sort | Eiichiro Noguchi |
| collection | DOAJ |
| description | In recent years, numerous molecular-targeted drugs have become available for the perioperative therapy of breast cancer, bringing about a revolution in breast cancer treatment. Based on comprehensive gene expression analysis, breast cancer is classified into four subtypes, and there are limitations regarding the drugs that can be used depending on the subtype and the cancer progression. Therefore, it is necessary to identify and select the appropriate drugs for each subtype. This review explores the expanded indications of four recently available molecular-targeted drugs in breast cancer treatment. |
| format | Article |
| id | doaj-art-2f28d22739354c7b96296504c09bc865 |
| institution | Kabale University |
| issn | 2432-6186 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | Society of Tokyo Women's Medical University |
| record_format | Article |
| series | Tokyo Women's Medical University Journal |
| spelling | doaj-art-2f28d22739354c7b96296504c09bc8652024-12-25T02:28:56ZengSociety of Tokyo Women's Medical UniversityTokyo Women's Medical University Journal2432-61862024-06-01801910.24488/twmuj.2024003twmujExpanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast CancerEiichiro Noguchi0Sadako Akashi-Tanaka1Division of Breast Surgery, Department of Surgery, Tokyo Women's Medical University School of MedicineDivision of Breast Surgery, Department of Surgery, Tokyo Women's Medical University School of MedicineIn recent years, numerous molecular-targeted drugs have become available for the perioperative therapy of breast cancer, bringing about a revolution in breast cancer treatment. Based on comprehensive gene expression analysis, breast cancer is classified into four subtypes, and there are limitations regarding the drugs that can be used depending on the subtype and the cancer progression. Therefore, it is necessary to identify and select the appropriate drugs for each subtype. This review explores the expanded indications of four recently available molecular-targeted drugs in breast cancer treatment.https://www.jstage.jst.go.jp/article/twmuj/8/0/8_2024003/_pdf/-char/ensubtypecdk 4/6 inhibitorsimmune checkpoint inhibitorsanti-her2 drugparp inhibitors |
| spellingShingle | Eiichiro Noguchi Sadako Akashi-Tanaka Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer Tokyo Women's Medical University Journal subtype cdk 4/6 inhibitors immune checkpoint inhibitors anti-her2 drug parp inhibitors |
| title | Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer |
| title_full | Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer |
| title_fullStr | Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer |
| title_full_unstemmed | Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer |
| title_short | Expanded Indications of Molecular-Targeted Drugs in Perioperative Therapy of Breast Cancer |
| title_sort | expanded indications of molecular targeted drugs in perioperative therapy of breast cancer |
| topic | subtype cdk 4/6 inhibitors immune checkpoint inhibitors anti-her2 drug parp inhibitors |
| url | https://www.jstage.jst.go.jp/article/twmuj/8/0/8_2024003/_pdf/-char/en |
| work_keys_str_mv | AT eiichironoguchi expandedindicationsofmoleculartargeteddrugsinperioperativetherapyofbreastcancer AT sadakoakashitanaka expandedindicationsofmoleculartargeteddrugsinperioperativetherapyofbreastcancer |